PLWH

Hepatitis delta infection among persons living with HIV in Europe

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV

HIV 보균자에서 비활성화된 SARS-CoV-2 백신의 안전성 및 면역원성

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis

Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study

HIV 보균자에서 비활성화된 SARS-CoV-2 백신의 면역원성과 안전성: 단면 연구

Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 백신 BNT162b2 또는 mRNA-1273 투여 후 면역저하 환자의 항체 반응: 무작위 대조 시험

Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study

Post-mRNA 예방접종 후 중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 면역글로불린 G(IgG) 농도 및 HIV(인간면역결핍바이러스)에 의한 대리바이러스 중화시험 반응의 차이 백신의 상태 및 유형: 일치된 사례-대조군 관찰 공부하다

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count

현재 CD4 T-림프구 수를 기반으로 항레트로바이러스 치료를 받고 있는 인간 면역결핍 바이러스에 감염된 사람들의 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 mRNA 백신 접종으로 유도된 체액 및 세포 면역 반응